Early Results Of Long-Acting Injectable HIV Treatment Study Show Promise Of Simplified Treatment For Patients In Resource-Limited Settings

Center for Global Health Policy’s “Science Speaks”: Long-acting injectable HIV treatment shows promise in early study results
Antigone Barton, senior writer and editor of “Science Speaks,” discusses results from a study that “show an injected combination of two antiretroviral medicines given monthly or every two months [is] effective in controlling HIV among people whose virus was already suppressed. … [The study findings] potentially offer the hope of simplified treatment for patients worldwide in resource-limited settings where obstacles to daily treatment remain greatest…” (11/3).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.